Antibiotice (BSE:ATB) Ending Cash Position : lei0.4 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Ending Cash Position?

Antibiotice's Ending Cash Position for the quarter that ended in Mar. 2024 was lei0.4 Mil.

Antibiotice's quarterly Ending Cash Position declined from Sep. 2023 (lei3.2 Mil) to Dec. 2023 (lei1.8 Mil) and declined from Dec. 2023 (lei1.8 Mil) to Mar. 2024 (lei0.4 Mil).

Antibiotice's annual Ending Cash Position increased from Dec. 2021 (lei-74.3 Mil) to Dec. 2022 (lei1.7 Mil) and increased from Dec. 2022 (lei1.7 Mil) to Dec. 2023 (lei1.8 Mil).

Antibiotice Ending Cash Position Historical Data

The historical data trend for Antibiotice's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Ending Cash Position Chart

Antibiotice Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

-124.00

-81.19

-74.32

1.73

1.81

Antibiotice Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															0.74	0.37	3.17	1.81	0.36

Antibiotice Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Antibiotice's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.728	+	0.079999999999999
	=	1.8

Antibiotice's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.808	+	-1.453
	=	0.4

Antibiotice Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Antibiotice's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Antibiotice (BSE:ATB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Valea Lupului Street, Iasi, ROU, 707410

Website

http://www.antibiotice.ro

Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines